CU-04

N/A

Report date: 2023/02/18 19:34:55

Base Information

Drug NameCU-04
Drug Alias NameCU-04
ClassificationSmall molecules
Mechanisms of ActionTranscriptional activator Myb inhibitorsT lymphocytes inhibitors
TargetsTranscriptional activator Myb
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCuracle Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCuracle Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A